Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)Francesco Patti, Diego Centonze, Paola Banfi et al.|Multiple Sclerosis and Related Disorders|2020Cited by 33
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS studyMaria Pia Amato, María Trojano, Roberto Bergamaschi et al.|Journal of Neurology|2023Cited by 2